Drug Shortage Report for RAN-ENALAPRIL

Last updated on 2019-07-06 History
Report ID 72782
Drug Identification Number 02352249
Brand name RAN-ENALAPRIL
Common or Proper name RAN-ENALAPRIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) ENALAPRIL SODIUM
Strength(s) 4MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-01-17
Actual start date 2019-01-17
Estimated end date 2019-07-07
Actual end date 2019-07-05
Shortage status Resolved
Updated date 2019-07-06
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2019-07-06 English Compare
v21 2019-07-05 French Compare
v20 2019-07-05 English Compare
v19 2019-06-07 French Compare
v18 2019-06-07 English Compare
v17 2019-05-13 French Compare
v16 2019-05-13 English Compare
v15 2019-04-05 French Compare
v14 2019-04-05 English Compare
v13 2019-03-22 French Compare
v12 2019-03-22 English Compare
v11 2019-03-15 French Compare
v10 2019-03-15 English Compare
v9 2019-02-15 French Compare
v8 2019-02-15 English Compare
v7 2019-02-11 French Compare
v6 2019-02-11 English Compare
v5 2019-02-04 French Compare
v4 2019-02-04 English Compare
v3 2019-01-18 English Compare

Showing 1 to 20 of 22